Although MSI pancreatic cancers are reported to be associated with KRAS‐TP53 wild type and JAK gene mutations,13 only one case was KRAS‐TP53 wild type, and no JAK mutations were found among the eight cases listed in Table 3. This evidence concerns the gene KRAS and familial pancreatic carcinoma.